Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
11,273,521
-
Shares change
-
-148,651
-
Total reported value, excl. options
-
$63,103,949
-
Value change
-
-$835,989
-
Put/Call ratio
-
213%
-
Number of buys
-
2
-
Number of sells
-
-8
-
Price
-
$5.63
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2022
28 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2022.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,273,521 shares
of 27,691,200 outstanding shares and own 41% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4,077,214 shares), Sonic Fund II, L.P. (2,407,357 shares), DG Capital Management, LLC (1,210,638 shares), Avoro Capital Advisors LLC (1,200,000 shares), Solas Capital Management, LLC (1,173,516 shares), 683 Capital Management, LLC (425,338 shares), MILLENNIUM MANAGEMENT LLC (237,392 shares), HARBERT FUND ADVISORS, INC. (189,750 shares), Tamar Securities, LLC (53,475 shares), and BlackRock Inc. (51,369 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.